• Five Pointers on Malignant Glaucoma

    July/August

    Read Article
  • Five Pointers on Bleb Leaks

    Strategies for proper detection and successful management.

    Read Article
  • Five Pointers on Glaucoma Drainage Device Exposure

    Fundamental tips that may help prevent vision-threating endophthalmitis.

    Read Article
  • Five Pointers on Neovascular Glaucoma With Active Neovascularization

    Strategies for detection, intervention, and prevention of rapid damage from IOP elevation.

    Read Article
  • Five Pointers on Choroidal Effusion and Suprachoroidal Hemorrhage

    How to avoid, recognize, and manage these conditions as a glaucoma specialist today.

    Read Article
  • Five Pointers on Glaucoma in Pregnancy

    All stages of childbearing, from before conception to lactation, must be considered.

    Read Article
  • Sustained-Release Devices for the Treatment of Chronic Eye Dseases

    Read Article
  •  
  • Glaucoma Expert Opinions
  • MIGS Resource center
  • Glaucoma 360
  • MIGS Experts on abic with itrack
  • Articles From This Issue


     

    COVER FOCUS

    Five Pointers on Malignant Glaucoma

    Prompt recognition and treatment are essential to reduce the risk of vision loss.

    COVER FOCUS

    Five Pointers on Bleb Leaks

    A look at emerging technologies targeting the suprachoroidal space.

    COVER FOCUS

    Five Pointers on Glaucoma Drainage Device Exposure

    Fundamental tips that may help prevent vision-threating endophthalmitis.

     

    Supplements and CME


    Sustained-Release Devices for the Treatment of Chronic Eye Dseases

    Supported through an educational grant by Allergan and EyePoint Pharmaceuticals.

    Current and Future Glaucoma Management: An Update on Existing Options and the Therapeutic Pipeline

    This activity is supported by an unrestricted educational grant from Bausch + Lomb.

    NEWS


     

    EyeGate Pharma Submits Investigational Device Exemption Amendment for Second Pil…

    EyeGate Pharmaceuticals announced that it has submitted an amended Investigational Device Exemption …

    Icon Bioscience Receives FDA Approval for Dexycu Drug Therapy for Treating Infla…

    Icon Bioscience announced that the FDA has approved the company's new drug application for Dexyc…

     

    EyeGate Announces Topline Results for Phase 2b Trial of EGP-437 in Cataract Surg…

    EyeGate Pharmaceuticals announced topline results from a phase 2b study of EGP-437 combination produ…

    Patients Are Going Blind Due to 6-Month Waiting Lists for Cataract Surgery

    Patients face going blind while waiting for cataract surgery after new figures showed waiting times …

    Featured Content


    Contact Info

    Bryn Mawr Communications LLC
    1008 Upper Gulph Road, Suite 200
    Wayne, PA 19087

    Phone: 484-581-1800
    Fax: 484-581-1818

    About Glaucoma Today

    Glaucoma Today is mailed bimonthly (six times a year) to 11,519 glaucoma specialists, general ophthalmologists, and clinical optometrists who treat patients with glaucoma. Glaucoma Today delivers important information on recent research, surgical techniques, clinical strategies, and technology.